Sign in

CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company

Amylyx Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464600503
Phone
617-682-0917
Business address
55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,951,125
in 9 filings, $8.0M under 10b5-1 plans

Net −$10,951,125. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cohen Joshua B −$4.0M Co-Chief Executive Officer sold 4% of stake
  2. Klee Justin B. −$4.0M Co-Chief Executive Officer sold 4% of stake
  3. FRATES JAMES M −$1.6M Chief Financial Officer sold 18% of stake
  4. MILNE GEORGE M JR −$831K Director sold 4% of stake
  5. Bedrosian Camille L −$325K Chief Medical Officer sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2023-03-16 FRATES JAMES M Chief Financial Officer Grant or award · Stock Option (right to buy) +97,500 97,500
2023-03-16 FRATES JAMES M Chief Financial Officer Option exercise · Stock Option (right to buy) −32,500 414,500
2023-03-16 Yeramian Patrick D Chief Medical Officer Option exercise +2,789 $0.33 $920 207,088
2023-03-16 Yeramian Patrick D Chief Medical Officer Option exercise +30,041 $0.37 $11K 237,129
2023-03-16 Yeramian Patrick D Chief Medical Officer Option exercise +16,748 $6.88 $115K 253,877
2023-03-16 Yeramian Patrick D Chief Medical Officer Sale −52,211 $31.85 $1.7M 201,666
2023-03-16 Yeramian Patrick D Chief Medical Officer Sale −2,416 $32.43 $78K 199,250
2023-03-16 Yeramian Patrick D Chief Medical Officer Grant or award +9,167 208,417
2023-03-16 Yeramian Patrick D Chief Medical Officer Grant or award · Stock Option (right to buy) +41,250 41,250
2023-03-16 Yeramian Patrick D Chief Medical Officer Option exercise · Stock Option (right to buy) −2,789 0
2023-03-16 Yeramian Patrick D Chief Medical Officer Option exercise · Stock Option (right to buy) −30,041 62,466
2023-03-16 Yeramian Patrick D Chief Medical Officer Option exercise · Stock Option (right to buy) −16,748 48,252
2023-03-16 Klee Justin B. Co-Chief Executive Officer Sale −96,555 $31.84 $3.1M 2,796,062
2023-03-16 Klee Justin B. Co-Chief Executive Officer Sale −3,445 $32.48 $112K 2,792,617
2023-03-16 Klee Justin B. Co-Chief Executive Officer Grant or award +50,000 2,842,617
2023-03-16 Klee Justin B. Co-Chief Executive Officer Grant or award · Stock Option (right to buy) +225,000 225,000
2023-03-16 Olinger Margaret Chief Commercial Officer Grant or award +18,333 232,688
2023-03-16 Olinger Margaret Chief Commercial Officer Grant or award · Stock Option (right to buy) +82,500 82,500
2023-03-16 MILNE GEORGE M JR Director Sale −33,084 $31.86 $1.1M 863,937
2023-03-16 MILNE GEORGE M JR Director Sale −1,916 $32.45 $62K 862,021

Page 12 of 19 · 362 trades